NASDAQ
28.82USD
+1.63 (+5.99%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.5B
P/E
—
EPS
—
Beta
2.02
52W range
20.13-41.223
Day range
27.54–29.04
Open
27.54
Prev close
27.19
Volume
746.2K
Avg volume
1.5M
Dividend
0.00
IPO
2025-08-07
https://seekingalpha.com/article/4921387-heartflow-stock-premium-ai-diagnostics-story · 7/12/2026+1.00
https://www.fool.com/coverage/better-buy/2026/07/04/heartflow-vs-iovance-biotherapeutics-which-healthcare-stock-is-a-better-buy-in-2026/ · 7/4/2026+0.30
https://www.defenseworld.net/2026/04/05/max-rosett-sells-65000-shares-of-immunome-nasdaqimnm-stock.html · 4/5/2026-0.30
https://www.defenseworld.net/2026/04/05/campbell-rogers-sells-64533-shares-of-heartflow-nasdaqhtfl-stock.html · 4/5/2026-0.20
https://www.defenseworld.net/2026/03/22/john-c-m-farquhar-sells-9725-shares-of-heartflow-nasdaqhtfl-stock.html · 3/22/2026-0.10
https://www.fool.com/investing/2025/12/18/why-ai-stock-heartflow-triumphed-on-thursday/ · 12/19/2025+1.00
https://www.globenewswire.com/news-release/2025/12/18/3208182/0/en/Heartflow-Plaque-Analysis-Now-Supported-by-Scientific-Statements-From-American-College-of-Cardiology-and-American-Heart-Association-for-Personalized-Management-of-Patients-with-Sus.html · 12/18/2025+1.00
https://www.fool.com/coverage/filings/2025/11/30/billionaire-family-office-acquires-usd65-million-of-heartflow-as-stock-jumps-70-from-ipo/ · 11/30/2025+0.80
https://www.globenewswire.com/news-release/2025/11/09/3184156/0/en/AHA-2025-Late-Breaking-Data-Reinforce-the-Prognostic-Power-of-AI-Driven-Heartflow-Plaque-Analysis-as-the-Most-Clinically-Validated-Framework-for-Coronary-Risk-Stratification.html · 11/9/2025+1.00
https://www.globenewswire.com/news-release/2025/09/22/3154301/0/en/Heartflow-Announces-FDA-510-k-Clearance-and-Launch-of-Next-Generation-Heartflow-Plaque-Analysis-Platform.html · 9/22/2025+1.00
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
